(STRM) Streamline Health Solutions - Ratings and Ratios

Streamline Health Solutions, Inc. is a health information technology company that provides innovative solutions to hospitals and health systems in North America, enabling them to optimize revenue cycle management, reduce revenue leakage, and improve financial performance. The companys suite of cloud-based and on-premise software solutions, including RevID, eValuator, Data Comparison Engine, and CDI, are designed to streamline clinical and billing processes, enhance productivity, and provide real-time financial insights.

By leveraging its software as a service (SaaS) solutions, healthcare providers can automate daily charge reconciliation, coding analysis, and system synchronization, resulting in improved accuracy, reduced errors, and increased revenue realization. Additionally, Streamline Health Solutions offers auditing and coding, software, and professional services to support its clients revenue cycle management needs. The companys solutions are sold through a direct sales force and reseller partnerships, allowing it to effectively reach and serve its target market.

From a technical analysis perspective, the stock has been trending downward, with the short-term and long-term moving averages (SMA20, SMA50, and SMA200) indicating a bearish sentiment. The Average True Range (ATR) of 0.23, representing 10.59% of the last price, suggests relatively high volatility. Given the current price of $2.18, the stock is trading near its 52-week low of $1.86, but still significantly below its 52-week high of $9.60. A potential trading opportunity may arise if the stock can break through the SMA20 resistance level at $2.63.

Fundamentally, Streamline Health Solutions has a relatively small market capitalization of $11.24M, and the absence of a price-to-earnings (P/E) ratio and forward P/E ratio indicates that the company is not profitable. The return on equity (RoE) of -68.42% further highlights the companys financial challenges. However, if the company can successfully execute its business strategy and improve its financial performance, it may be able to drive growth and increase its stock price.

Based on the technical and fundamental data, a potential forecast for Streamline Health Solutions is that the stock may continue to experience volatility in the short term, with potential support at the 52-week low of $1.86. However, if the company can demonstrate significant improvements in its financial performance and execute on its business strategy, it may be able to drive a rebound in the stock price, potentially targeting the SMA200 level at $3.62 in the medium term.